Blog

The Cancer Research Institute Has Announced the Spring 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows

Photo: cancerresearch.org

Jun 27, 2025, 17:09

The Cancer Research Institute Has Announced the Spring 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows

Cancer Research Institute (CRI) shared a post on LinkedIn:

“The Cancer Research Institute is excited to announce the Spring 2025 Class of CRI Irvington and Immuno-Informatics Postdoctoral Fellows– future leaders whose innovative ideas and scientific ingenuity are helping to reshape the future of cancer treatment!

This cohort marks the first selected since CRI pledged an emergency $2.5 million to fund an additional 10 postdoctoral fellowships over the next year—part of a bold response to mounting uncertainty in federal research funding. In a further show of support, CRI also offered all its current fellows in their final year of funding a six-month extension to help ensure continuity and stability during this turbulent time.

‘Our investment is both a promise kept and a reaffirmation of CRI’s mission,’ emphasizes CRI’s CEO, Alicia Zhou, PhD. ‘These are the scientists who will shape the future of cancer treatment. We’re proud to stand behind them—not just with words, but with real resources that allow bold scientific exploration to be done. ‘

Meet these outstanding scientists.”

Alicia Zhou, CEO at Cancer Research Institute, shared this post, adding:

“The future of cancer research depends on the people bold enough to push it forward.

That’s why I’m especially proud to share the Spring 2025 Class of CRI Postdoctoral Fellows—the first selected since we made an emergency $2.5M commitment to fund 10 additional fellowships this year. These early-career scientists are asking the big questions and charting the paths that will define tomorrow’s breakthroughs.

In moments of funding uncertainty, it’s easy to cut back. But at Cancer Research Institute (CRI), we’ve chosen to double down—because investing in trainees is one of the most powerful ways we can safeguard the future of the field. That’s also why we offered every postdoc in their final year of CRI support a 6-month extension, ensuring stability at a time when continuity is more important than ever.

To our fellows: we believe in your vision, and we’re here to help you see it through.”

More posts featuring Cancer Research Institute.